FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1605156779> ?p ?o ?g. }

• W1605156779 endingPage "541" @default.
• W1605156779 startingPage "532" @default.
• W1605156779 abstract "Abstract The selective targeting of the tumor-associated death-inducing receptors DR4 and DR5 with agonistic mAbs has demonstrated preclinical and clinical antitumor activity. However, the cellular and molecular mechanisms contributing to this efficacy remain poorly understood. In this study, using the first described C57BL/6 (B6) TRAIL-sensitive experimental tumor models, we have characterized the innate and adaptive immune components involved in the primary rejection phase of an anti-mouse DR5 (mDR5) mAb, MD5-1 in established MC38 colon adenocarcinomas. FcR mediated cross-linking of MD5-1 significantly inhibited the growth of MC38 colon adenocarcinomas through the induction of TRAIL-R–dependent tumor cell apoptosis. The loss of host DR5, TRAIL, perforin, FasL, or TNF did not compromise anti-DR5 therapy in vivo. By contrast, anti-DR5 therapy was completely abrogated in mice deficient of B cells or CD11c+ dendritic cells (DCs), providing the first direct evidence that these cells play a critical role. Importantly, the requirement for an intact B cell compartment for optimal anti-DR5 antitumor efficacy was also observed in established AT-3 mammary tumors. Interestingly, MD5-1–mediated apoptosis as measured by early TUNEL activity was completely lost in B cell-deficient μMT mice, but intact in mice deficient in CD11c+ DCs. Overall, these data show that Ab-mediated targeting of DR5 triggers tumor cell apoptosis in established tumors in a B cell-dependent manner and that CD11c+ DCs make a critical downstream contribution to anti-DR5 antitumor activity." @default.
• W1605156779 created "2016-06-24" @default.
• W1605156779 creator A5017408026 @default.
• W1605156779 creator A5026944433 @default.
• W1605156779 creator A5032904463 @default.
• W1605156779 creator A5048310212 @default.
• W1605156779 creator A5049789656 @default.
• W1605156779 creator A5050894148 @default.
• W1605156779 creator A5055053148 @default.
• W1605156779 creator A5060763507 @default.
• W1605156779 creator A5061575707 @default.
• W1605156779 creator A5066441338 @default.
• W1605156779 creator A5070494006 @default.
• W1605156779 creator A5074513079 @default.
• W1605156779 creator A5078092097 @default.
• W1605156779 date "2010-07-01" @default.
• W1605156779 modified "2023-09-26" @default.
• W1605156779 title "CD11c+ Dendritic Cells and B Cells Contribute to the Tumoricidal Activity of Anti-DR5 Antibody Therapy in Established Tumors" @default.
• W1605156779 cites W1493742659 @default.
• W1605156779 cites W1527985047 @default.
• W1605156779 cites W1594149454 @default.
• W1605156779 cites W1966930760 @default.
• W1605156779 cites W1967014996 @default.
• W1605156779 cites W197699128 @default.
• W1605156779 cites W1983914264 @default.
• W1605156779 cites W2003303180 @default.
• W1605156779 cites W2010690292 @default.
• W1605156779 cites W2019276845 @default.
• W1605156779 cites W2039609199 @default.
• W1605156779 cites W2046505430 @default.
• W1605156779 cites W2047902191 @default.
• W1605156779 cites W2058837304 @default.
• W1605156779 cites W2060294539 @default.
• W1605156779 cites W2061982934 @default.
• W1605156779 cites W2072359530 @default.
• W1605156779 cites W2076610281 @default.
• W1605156779 cites W2078373518 @default.
• W1605156779 cites W2081894694 @default.
• W1605156779 cites W2092191659 @default.
• W1605156779 cites W2093424661 @default.
• W1605156779 cites W2097931076 @default.
• W1605156779 cites W2099878269 @default.
• W1605156779 cites W2108556253 @default.
• W1605156779 cites W2113505777 @default.
• W1605156779 cites W2120943145 @default.
• W1605156779 cites W2132719717 @default.
• W1605156779 cites W2144037068 @default.
• W1605156779 cites W2148244207 @default.
• W1605156779 cites W2161888789 @default.
• W1605156779 cites W4235493536 @default.
• W1605156779 cites W76644046 @default.
• W1605156779 doi "https://doi.org/10.4049/jimmunol.0903624" @default.
• W1605156779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20505139" @default.
• W1605156779 hasPublicationYear "2010" @default.
• W1605156779 type Work @default.
• W1605156779 sameAs 1605156779 @default.
• W1605156779 citedByCount "51" @default.
• W1605156779 countsByYear W16051567792012 @default.
• W1605156779 countsByYear W16051567792013 @default.
• W1605156779 countsByYear W16051567792014 @default.
• W1605156779 countsByYear W16051567792015 @default.
• W1605156779 countsByYear W16051567792016 @default.
• W1605156779 countsByYear W16051567792017 @default.
• W1605156779 countsByYear W16051567792018 @default.
• W1605156779 countsByYear W16051567792019 @default.
• W1605156779 countsByYear W16051567792020 @default.
• W1605156779 countsByYear W16051567792021 @default.
• W1605156779 countsByYear W16051567792022 @default.
• W1605156779 countsByYear W16051567792023 @default.
• W1605156779 crossrefType "journal-article" @default.
• W1605156779 hasAuthorship W1605156779A5017408026 @default.
• W1605156779 hasAuthorship W1605156779A5026944433 @default.
• W1605156779 hasAuthorship W1605156779A5032904463 @default.
• W1605156779 hasAuthorship W1605156779A5048310212 @default.
• W1605156779 hasAuthorship W1605156779A5049789656 @default.
• W1605156779 hasAuthorship W1605156779A5050894148 @default.
• W1605156779 hasAuthorship W1605156779A5055053148 @default.
• W1605156779 hasAuthorship W1605156779A5060763507 @default.
• W1605156779 hasAuthorship W1605156779A5061575707 @default.
• W1605156779 hasAuthorship W1605156779A5066441338 @default.
• W1605156779 hasAuthorship W1605156779A5070494006 @default.
• W1605156779 hasAuthorship W1605156779A5074513079 @default.
• W1605156779 hasAuthorship W1605156779A5078092097 @default.
• W1605156779 hasBestOaLocation W16051567791 @default.
• W1605156779 hasConcept C104317684 @default.
• W1605156779 hasConcept C127716648 @default.
• W1605156779 hasConcept C154317977 @default.
• W1605156779 hasConcept C190283241 @default.
• W1605156779 hasConcept C193419808 @default.
• W1605156779 hasConcept C202751555 @default.
• W1605156779 hasConcept C203014093 @default.
• W1605156779 hasConcept C2779919695 @default.
• W1605156779 hasConcept C39347974 @default.
• W1605156779 hasConcept C502942594 @default.
• W1605156779 hasConcept C55493867 @default.
• W1605156779 hasConcept C86803240 @default.
• W1605156779 hasConcept C8891405 @default.
• W1605156779 hasConceptScore W1605156779C104317684 @default.

• next